- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04932343
Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor
June 18, 2021 updated by: Jhingook Kim, MD, Samsung Medical Center
Comparison of Genomic and Transcriptomic Patterns Between the Circulating Tumor Cells and Metastatic Tumor Cells, and Their Specific Relevance to Circulating Tumor DNAs: Quest for Any Distinct or Complementary Roles of CTCs and ctDNAs to Understand the Metastasis in Advanced NSCLC
This study aims to understand the metastasis in advanced NSCLC through comparing genomic and transcriptomic patterns between the circulating tumor cells and metastatic tumor cells by single cell sequencing analysis.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 06351
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Treatment naïve stage III-IV non-small cell lung cancer who undergoing surgery for any intent
Description
Inclusion Criteria:
- All subjects need to sign the informed consent form
- All subjects have non-small cell lung cancer which suspected on chest CT or confirmed pathologically preoperatively
- Treatment naïve advanced lung cancer (including extensive stage IIIb and stage IV)
- Patients who were suitable to provide enough metastatic tumor tissue and blood (30ml) for the single cells sequencing
Exclusion Criteria:
- Patients with previous history of lung cancer
- Have been undergone chemotherapy or radiotherapy due to non-small call lung cancer
- Have been diagnosed any type of cancer other than cancer of skin, thyroid, uterine cervix within 5 years before enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The gene expression and the cell population
Time Frame: 3 year
|
Methods for the single cell RNA sequencing and whole exome sequencing of the tumor cells With the tissue biopsied specimens, scRNAseq (by 10X Genomics platform) and whole exome seq will be carried out.
|
3 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Jhingook Kim, MD, Samsung Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Anticipated)
June 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
June 13, 2021
First Submitted That Met QC Criteria
June 18, 2021
First Posted (Actual)
June 21, 2021
Study Record Updates
Last Update Posted (Actual)
June 21, 2021
Last Update Submitted That Met QC Criteria
June 18, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB 2019-07-101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on NSCLC Stage IV
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Spanish Lung Cancer GroupCompleted
-
Niguarda HospitalUniversity of Turin, Italy; Fondazione del Piemonte per l'OncologiaCompleted
-
Mylan Pharmaceuticals IncCompletedNSCLC Stage IVTurkey, Taiwan, Vietnam, Croatia, India, Russian Federation, Spain, Hungary, Bosnia and Herzegovina, Ukraine, Poland, Romania, Belarus, Bulgaria, Georgia, Italy, Philippines
-
Instituto do Cancer do Estado de São PauloUnknown
-
Xiaorong DongUnknownHealthy Subjects | NSCLC Stage IV | NSCLC, Stage III | NSCLC, Stage I | NSCLC, Stage IIChina
-
Microbio Co LtdRecruiting
-
The Netherlands Cancer InstituteBristol-Myers SquibbTerminated
-
Fudan UniversityUnknown
-
KangLaiTe USATerminatedStage IV NSCLCUnited States
Clinical Trials on cohort study
-
Vanderbilt University Medical CenterRecruitingCovid19 | Pulmonary Fibrosis | Sars-CoV-2 Infection | COVID-19 Acute Respiratory Distress Syndrome | Dyspnea Caused by 2019-nCoVUnited States
-
Hannover Medical SchoolUnknownCommunity Acquired PneumoniaGermany
-
European Foundation for the Care of Newborn InfantsRespiratory Syncytial Virus Foundation (ReSViNET); European Society for Paediatric... and other collaboratorsRecruitingQuality of Life | Caregiver Burden | Infant ALL | RSV Infection | FamilyGermany
-
Lawson Health Research InstituteRecruitingKnee Osteoarthritis | Hip OsteoarthritisCanada
-
Alopexx Vaccine, LLCCompletedPNAG-expressing Pathogenic Microbes VaccineUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Sorbonne... and other collaboratorsNot yet recruitingImmune System Diseases | Lymphoma | Lymphoproliferative Disorders | Autoimmune Diseases | Inflammation | Myelodysplastic Syndromes | Hematologic Diseases | Leukemia | Myeloproliferative Disorders | Myelodysplastic-Myeloproliferative Diseases | Monoclonal Gammopathy of Undetermined Significance | Autoinflammatory... and other conditions
-
Temple UniversityNational Institute on Minority Health and Health Disparities (NIMHD); National...Active, not recruitingSmoking | Lung Diseases | SleepUnited States
-
Vrije Universiteit BrusselUniversity Ghent; Research Foundation FlandersNot yet recruiting
-
Children's Hospital of Fudan UniversityCompletedVLBW - Very Low Birth Weight InfantChina
-
Vestre VikenHF Kongsberg SykehusUnknownDevelopmental Dysplasia of the Hip (DDH)Norway